Shirish Agarwal
Breaking News To Trading Moves
Breaking News to Trading Moves delivers fast, actionable trading ideas straight from the headlines. Each episode cuts through the noise of daily news and translates it into clear short- and long-term trade setups you can actually use. Whether it’s earnings surprises, policy shifts, or market-moving events, you’ll get sharp insights on which stocks, sectors, and themes to watch. Perfect for traders who want to stay ahead of the market without wasting time, this podcast gives you the edge to turn breaking news into smart trading moves.
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Architects of Industry: The QXO and TopBuild Consolidation Wave 20.04.2026 17:43
QXO buys TopBuild: what the building products consolidation wave means for U.S. stocks QXO is acquiring TopBuild in a $17 billion deal. The transaction would make QXO the 2nd-largest publicly traded building products distributor in North America, with more than $18 billion in combined revenue. Winners Building products distributors with scale advantages This deal reinforces the idea that scale mat...
Risk Management Is Killing Your Profits 18.04.2026 17:26
In this episode of Breaking News to Trading Moves , the discussion focuses on one of the biggest debates in trading: is long-term success driven more by having a genuine mathematical edge, or by strict risk management and psychological discipline? The episode breaks down why a trader can win often and still lose over time, while another trader can have a lower win rate and still build real wealth....
Truist Earnings and the Resurgence of U.S. Capital Markets 18.04.2026 10:48
Truist beats on trading and investment banking: what the read-through means for U.S. bank stocks Truist beat 1st-quarter profit expectations as stronger investment banking fees, higher trading income, and higher net interest income helped results. Investment banking and trading income rose 36.3%, net interest income increased 2.5% to $3.64 billion, EPS came in at $1.09 versus $0.99 expected, and t...
The Schwab Shift: Brokerage Evolution 17.04.2026 19:15
Charles Schwab’s Record Profit: What It Means For Brokers, Trading Platforms And Financial Stocks Charles Schwab posted record first-quarter profit, helped by strong client growth, higher trading activity and stronger engagement across wealth, trading and lending. This is not just a Schwab story. It has a wider read-through for online brokers, wealth platforms, market makers, exchanges, asset mana...
Buy And Hold Can Be A Lazy Strategy, Not A Smart One 17.04.2026 23:51
Market Timing Vs Buy And Hold: Which Strategy Really Gives Investors The Edge? Market timing sounds exciting. Buy and hold sounds boring. But which approach actually works better for ordinary investors trying to build wealth without getting destroyed by bad entries, emotional decisions, or market noise? In this episode of Breaking News To Trading Moves, we break down the debate between market timi...
Long Term Investing Is Overrated For Ordinary People 16.04.2026 21:32
Passive investing is often presented as the safest and simplest path for long-term investors. Low fees, broad diversification and consistent market exposure have made index funds and ETFs one of the most powerful forces in global finance. But what if passive indexing is no longer just a neutral investing tool? What if it has become a structural force that shapes price action, rewards size over fun...
Wall Street Rebound: Bank of America and the New Sector Outlook 16.04.2026 16:45
Bank of America beats on trading and dealmaking: what it means for bank stocks and private credit Bank of America beat profit estimates in Q1 as equities trading hit a record, investment banking fees rose 21%, and net interest income climbed 9%. Profit rose nearly 17% to $8.6 billion, while management also pointed to healthy client activity, solid consumer spending and stable asset quality. Why th...
The Resurgence of Diversified Banking and Capital Markets Strength 15.04.2026 16:25
Citi beats on trading and dealmaking: what the bank earnings read-through means for financial stocks Citigroup just posted a strong earnings beat, helped by a surge in trading revenue during a volatile quarter and better investment banking activity. Citi delivered its highest quarterly revenue in a decade, with total markets revenue up 19%, equity markets fees up 39%, and banking division revenue...
Technical Analysis Works, But Not In The Way You Think 14.04.2026 17:09
Technical Analysis: Real Edge or Psychological Illusion? In this episode of Breaking News to Trading Moves , we explore one of the biggest debates in trading: does technical analysis really give you an edge, or does it mostly create the illusion of control? What this episode covers: • Why traders are drawn to charts, patterns, and indicators • Whether support, resistance, trend lines, and setups t...
The Allogeneic Pivot: Reshaping the CAR-T Market Landscape 14.04.2026 15:25
Allogene Therapeutics surges on positive CAR-T trial data Allogene Therapeutics jumps after mid-stage data showed its off-the-shelf CAR-T therapy cut the risk of relapse in blood cancer patients, with shares up more than 55% in early trading. The key market read-through is that positive, clean safety data may improve sentiment toward the broader US-listed cell therapy and oncology biotech space, w...
Why Most Retail Traders Should Stop Using Stop Losses 13.04.2026 22:42
This episode examines the clash between 2 schools of thought. One side argues that stop losses are essential because markets can gap, news can hit without warning and technology can fail at the worst possible moment. The other side argues that visible stops create predictable pools of liquidity that larger players can exploit, especially when traders place them in obvious locations. Rather than tr...
Big U.S. Banks Post Results: What Earnings Mean for Financial Stocks 13.04.2026 17:50
Big US banks are about to post results, and the market is watching closely. Goldman Sachs starts the week, with JPMorgan, Citigroup, Wells Fargo, Morgan Stanley and Bank of America also in focus. The key theme is whether strong trading and investment banking results can outweigh worries about the economy, credit quality and 2026 guidance. Winners Money centre banks These are the large, diversified...
The CoreWeave Pivot: Scaling the AI Infrastructure Frontier 11.04.2026 15:42
CoreWeave has landed another major AI infrastructure customer. Anthropic has signed a multi-year deal with CoreWeave for cloud computing capacity, with rollout starting later in 2026. The market read-through is that leading AI model developers are still racing to secure compute wherever they can get it. That is supportive for GPU-heavy cloud providers, networking names, and data centre infrastruct...
The Silicon Shift: AI Beyond the GPU Narrative 11.04.2026 15:42
Intel and Google deepen AI CPU push: why the next AI trade may spread beyond GPUs Intel and Google are expanding their partnership around AI-focused CPUs and custom infrastructure processors. The key takeaway is that AI deployment is spreading beyond training into inference, enterprise workloads and broader data-centre computing. That could help parts of the server CPU, cloud infrastructure and ne...
The Ares Acquisition: Privatizing the Sunbelt Retail Market 10.04.2026 17:08
Whitestone REIT goes private: what the Ares deal means for retail REITs and private equity flows Whitestone REIT is getting taken private by Ares in an all-cash deal valued at about $1.7 billion, with Ares paying $19 per share or unit. That is a 12.2% premium to Whitestone’s prior close, and the deal is expected to close in Q3 2026 if shareholders approve it and other conditions are met. Winners D...
The Brown-Forman Takeover and Industry Shifts 10.04.2026 9:08
Brown-Forman bid battle: which U.S. beverage stocks could win or lose next? Brown-Forman attracts another bidder: Sazerac explores a deal for Jack Daniel’s owner, adding fresh takeover heat to the U.S. spirits space. Sazerac is exploring a deal for Brown-Forman, potentially joining talks already involving Pernod Ricard. Brown-Forman shares jumped as much as 14.9%, and the story matters because it...
Fuel Spikes: The Shifting Balance of Energy and Aviation 09.04.2026 13:08
Delta pulls growth plans as fuel spike pressures airline profits Delta Air Lines said it is halting planned capacity growth for Q2 2026 after a sharp jump in jet fuel costs tied to Middle East disruption. Delta expects more than $2 billion of extra fuel expense in the June quarter, sees jet fuel at about $4.30 per gallon, and guided Q2 earnings to $1.00 to $1.50 per share, below Wall Street expect...
Denim Resurgence and the Premium Apparel Shift 09.04.2026 20:46
Levi Strauss rallies as strong full-price denim sales lift apparel sentiment Levi Strauss $LEVI rose after reporting its strongest quarterly revenue growth in nearly 4 years, helped by demand for baggy jeans, stronger digital sales to younger customers, and enough pricing power to offset roughly 10% U.S. import tariff costs. Shares of other apparel and footwear names such as Abercrombie & Fitc...
The Ripple Effect of Automotive Quality and Recall Risks 08.04.2026 14:41
GM recall shakes auto sentiment as quality and supplier risks come into focus GM is recalling 271,770 vehicles in the US over a rearview camera issue affecting Chevrolet Malibu sedans, with NHTSA saying the screen may show a distorted or blank image and dealers will inspect and replace the camera. General Motors recall puts auto quality and supplier risk back in focus General Motors $GM (General M...
The Reality of AI Trading and the Finfluencer Phenomenon 07.04.2026 17:54
Why AI Trading Bots Hallucinate Profits and Finfluencers Sell the Fantasy In this episode, we dig into one of the biggest myths spreading across social media finance right now: the idea that AI trading bots, automated prompts, and finfluencer-backed systems can reliably turn everyday traders into market-beating machines. The pitch is always slick. A bot can scan charts faster than you, remove emot...
Broadcom and Google: The Custom AI Silicon Paradigm Shift 07.04.2026 8:36
Broadcom lands long-term Google AI chip deal through 2031: why custom silicon is becoming a bigger AI market theme Broadcom just signed a long-term agreement with Google to develop and supply future generations of custom AI chips and other components for Google’s next-generation AI racks through 2031. Broadcom also signed a deal tied to Anthropic’s access to about 3.5 gigawatts of AI computing cap...
Orbital Ambition: The Amazon-Globalstar Satellite Connectivity Shift 06.04.2026 18:56
Amazon eyes Globalstar: the satellite deal that could reshape space connectivity An Amazon-Globalstar deal is not just about 1 takeover target. It is a signal that low-earth-orbit satellite connectivity is becoming more strategic, more competitive, and more valuable. The most obvious winner is Globalstar, but the bigger market read-through is that Amazon may be willing to spend aggressively to sca...
Tesla Misses' Expectations Even As Q1 Sales Rise 06.04.2026 7:43
Tesla reported Q1 vehicle sales of 358,023, up 6% year over year, but still below the roughly 381,000 analysts were expecting. The stock sold off on the news, while Tesla continues trying to shift investor focus toward cheaper models, robotaxis and Optimus rather than just near-term car sales. Winners Traditional automakers with broader product mix If Tesla is still missing expectations despite pr...
The Rivian Surge and the Stabilizing EV Market Landscape 03.04.2026 8:14
Rivian beats delivery estimates as EV demand shows signs of stabilising Rivian Automotive $RIVN (Rivian) beat Wall Street’s Q1 delivery expectations, delivering 10,365 vehicles versus estimates of 9,678, while reiterating its full-year delivery forecast of 62,000 to 67,000 vehicles. The bigger takeaway is that EV demand may be stabilising, which could shift sentiment across U.S.-listed EV makers,...
Biogen and Apellis: Biotech Acquisition Market Dynamics 01.04.2026 15:10
Biogen Buys Apellis: Rare Disease Biotech Biogen is making one of the bigger biotech moves on the tape, agreeing to buy Apellis for about $5.6 billion in cash. The key trading angle is that this can lift sentiment around commercial-stage biotech and rare disease names that could be seen as future takeover candidates, while also putting pressure on Biogen itself as traders weigh the size, financing...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.